Annual CAPEX
$5.78 M
-$8.21 M-58.68%
December 31, 2024
Summary
- As of March 5, 2025, NTLA annual capital expenditures is $5.78 million, with the most recent change of -$8.21 million (-58.68%) on December 31, 2024.
- During the last 3 years, NTLA annual CAPEX has fallen by -$6.98 million (-54.70%).
- NTLA annual CAPEX is now -90.10% below its all-time high of $58.39 million, reached on December 31, 2022.
Performance
NTLA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$981.00 K
-$298.00 K-23.30%
December 31, 2024
Summary
- As of March 5, 2025, NTLA quarterly capital expenditures is $981.00 thousand, with the most recent change of -$298.00 thousand (-23.30%) on December 31, 2024.
- Over the past year, NTLA quarterly CAPEX has stayed the same.
- NTLA quarterly CAPEX is now -97.88% below its all-time high of $46.26 million, reached on March 31, 2022.
Performance
NTLA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$5.78 M
-$539.00 K-8.53%
December 31, 2024
Summary
- As of March 5, 2025, NTLA TTM capital expenditures is $5.78 million, with the most recent change of -$539.00 thousand (-8.53%) on December 31, 2024.
- Over the past year, NTLA TTM CAPEX has stayed the same.
- NTLA TTM CAPEX is now -90.10% below its all-time high of $58.39 million, reached on December 31, 2022.
Performance
NTLA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
NTLA CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.7% | 0.0% | 0.0% |
| 3 y3 years | -54.7% | -65.8% | -54.7% |
| 5 y5 years | -14.9% | -61.9% | -14.9% |
NTLA CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -90.1% | at low | -97.9% | at low | -90.1% | at low |
| 5 y | 5-year | -90.1% | +61.2% | -97.9% | +40.5% | -90.1% | +61.2% |
| alltime | all time | -90.1% | +126.2% | -97.9% | +90.1% | -90.1% | +1019.8% |
Intellia Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $5.78 M(-58.7%) | $981.00 K(-23.3%) | $5.78 M(-8.5%) |
| Sep 2024 | - | $1.28 M(+26.4%) | $6.32 M(-32.6%) |
| Jun 2024 | - | $1.01 M(-59.6%) | $9.37 M(-26.0%) |
| Mar 2024 | - | $2.51 M(+64.9%) | $12.66 M(-9.5%) |
| Dec 2023 | $13.98 M(-76.0%) | $1.52 M(-64.9%) | $13.98 M(-14.6%) |
| Sep 2023 | - | $4.33 M(+0.7%) | $16.38 M(+0.6%) |
| Jun 2023 | - | $4.30 M(+12.2%) | $16.28 M(+2.0%) |
| Mar 2023 | - | $3.83 M(-2.0%) | $15.96 M(-72.7%) |
| Dec 2022 | $58.39 M(+357.7%) | $3.91 M(-7.7%) | $58.39 M(+1.8%) |
| Sep 2022 | - | $4.24 M(+6.5%) | $57.35 M(-0.5%) |
| Jun 2022 | - | $3.98 M(-91.4%) | $57.65 M(+1.8%) |
| Mar 2022 | - | $46.26 M(+1513.0%) | $56.60 M(+343.8%) |
| Dec 2021 | $12.76 M(+255.8%) | $2.87 M(-36.8%) | $12.76 M(+17.1%) |
| Sep 2021 | - | $4.54 M(+54.5%) | $10.89 M(+54.4%) |
| Jun 2021 | - | $2.94 M(+21.8%) | $7.05 M(+36.9%) |
| Mar 2021 | - | $2.41 M(+139.8%) | $5.15 M(+43.7%) |
| Dec 2020 | $3.58 M(-47.2%) | $1.01 M(+44.1%) | $3.58 M(-30.4%) |
| Sep 2020 | - | $698.00 K(-32.6%) | $5.15 M(-16.9%) |
| Jun 2020 | - | $1.04 M(+22.6%) | $6.20 M(+1.6%) |
| Mar 2020 | - | $845.00 K(-67.1%) | $6.11 M(-10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $6.79 M(+6.9%) | $2.57 M(+47.1%) | $6.79 M(+16.9%) |
| Sep 2019 | - | $1.75 M(+85.8%) | $5.81 M(-4.4%) |
| Jun 2019 | - | $941.00 K(-38.6%) | $6.08 M(+0.7%) |
| Mar 2019 | - | $1.53 M(-3.7%) | $6.04 M(-5.0%) |
| Dec 2018 | $6.36 M(-37.0%) | $1.59 M(-21.0%) | $6.36 M(-11.2%) |
| Sep 2018 | - | $2.02 M(+124.0%) | $7.16 M(-3.3%) |
| Jun 2018 | - | $900.00 K(-51.4%) | $7.41 M(-4.8%) |
| Mar 2018 | - | $1.85 M(-22.8%) | $7.78 M(-22.9%) |
| Dec 2017 | $10.09 M(+63.7%) | $2.40 M(+6.1%) | $10.09 M(-9.1%) |
| Sep 2017 | - | $2.26 M(+77.7%) | $11.10 M(+17.5%) |
| Jun 2017 | - | $1.27 M(-69.4%) | $9.44 M(+1.3%) |
| Mar 2017 | - | $4.16 M(+22.2%) | $9.32 M(+51.2%) |
| Dec 2016 | $6.17 M(+141.4%) | $3.40 M(+462.8%) | $6.17 M(+70.8%) |
| Sep 2016 | - | $605.00 K(-47.3%) | $3.61 M(+0.1%) |
| Jun 2016 | - | $1.15 M(+13.8%) | $3.61 M(+18.4%) |
| Mar 2016 | - | $1.01 M(+18.7%) | $3.05 M(+19.3%) |
| Dec 2015 | $2.55 M | $849.00 K(+41.0%) | $2.55 M(+49.8%) |
| Sep 2015 | - | $602.00 K(+2.6%) | $1.71 M(+54.6%) |
| Jun 2015 | - | $587.00 K(+13.8%) | $1.10 M(+113.8%) |
| Mar 2015 | - | $516.00 K | $516.00 K |
FAQ
- What is Intellia Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Intellia Therapeutics?
- What is Intellia Therapeutics annual CAPEX year-on-year change?
- What is Intellia Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly CAPEX year-on-year change?
- What is Intellia Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Intellia Therapeutics?
- What is Intellia Therapeutics TTM CAPEX year-on-year change?
What is Intellia Therapeutics annual capital expenditures?
The current annual CAPEX of NTLA is $5.78 M
What is the all time high annual CAPEX for Intellia Therapeutics?
Intellia Therapeutics all-time high annual capital expenditures is $58.39 M
What is Intellia Therapeutics annual CAPEX year-on-year change?
Over the past year, NTLA annual capital expenditures has changed by -$8.21 M (-58.68%)
What is Intellia Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of NTLA is $981.00 K
What is the all time high quarterly CAPEX for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly capital expenditures is $46.26 M
What is Intellia Therapeutics quarterly CAPEX year-on-year change?
Over the past year, NTLA quarterly capital expenditures has changed by $0.00 (0.00%)
What is Intellia Therapeutics TTM capital expenditures?
The current TTM CAPEX of NTLA is $5.78 M
What is the all time high TTM CAPEX for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM capital expenditures is $58.39 M
What is Intellia Therapeutics TTM CAPEX year-on-year change?
Over the past year, NTLA TTM capital expenditures has changed by $0.00 (0.00%)